SCHEMBL491118

SCHEMBL491118

C=C(C)C(=O)OC(C)SC(C)OC(=O)C(=C)C

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.44
THRB P10828 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2429804 0.91 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL28847315 0.84 TSHR (0.41) TSHRALDH1A1THRB
SCHEMBL2430676 0.84 TSHR (0.43) TSHRALDH1A1THRBTDP1
SCHEMBL8944639 0.84 TSHR (0.43) TSHRALDH1A1THRBTDP1
SCHEMBL670914 0.82 TSHR (0.40) TSHRALDH1A1THRB
SCHEMBL27800273 0.82 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL28432487 0.82 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL21385093 0.81 TSHR (0.39) TSHRALDH1A1THRB
SCHEMBL671675 0.80 TSHR (0.45) TSHRALDH1A1THRB
SCHEMBL5010754 0.79 TSHR (0.39) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4599030-B1 A PYROLYSIS OIL WITH REDUCED POUR POINT EVONIK OPERATIONS GMBH (DE) 2026-03-25 EP claimed
EP-4594452-B1 A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY EVONIK OPERATIONS GMBH (DE) 2025-12-10 EP claimed
EP-4599030-A1 A PYROLYSIS OIL WITH REDUCED POUR POINT Evonik Operations GmbH (DE) 2025-08-13 EP claimed
EP-4594452-A1 A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY Evonik Operations GmbH (DE) 2025-08-06 EP claimed
WO-2025132054-A1 A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY EVONIK OPERATIONS GMBH (DE) 2025-06-26 WO claimed
WO-2025132057-A1 A PYROLYSIS OIL WITH REDUCED POUR POINT EVONIK OPERATIONS GMBH (DE) 2025-06-26 WO claimed
US-6194511-B1 COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND TOKUYAMA CORPORATION (JP) 2001-02-27 US claimed
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-05-21 US disclosed
EP-4599030-B1 A PYROLYSIS OIL WITH REDUCED POUR POINT EVONIK OPERATIONS GMBH (DE) 2026-03-25 EP disclosed
EP-3901185-B1 CURABLE COMPOSITION FOR OPTICAL MATERIALS, AND OPTICAL MATERIAL TOKUYAMA CORP (JP) 2026-03-25 EP disclosed
EP-4696722-A1 (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2026-02-18 EP disclosed
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article TOKUYAMA CORPORATION (JP) 2026-02-17 US disclosed
EP-4594452-B1 A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY EVONIK OPERATIONS GMBH (DE) 2025-12-10 EP disclosed
WO-2002038633-A2 METHOD FOR PRODUCING POLYMER COMPOSITIONS AND THE USE THEREOF ROHMAX ADDITIVES GMBH (DE) 2002-05-16 WO disclosed
US-20020002259-A1 LOW-ODOR, COLD-CURING (METH) ACRYLATE REACTION RESIN FOR FLOOR COATING, A FLOOR COATING CONTAINING THE REACTION RESIN, AND A PROCESS FOR THE PREPARATION OF THE FLOOR COATING ROEHM GMBH & CO KG (DE) 2002-01-03 US disclosed
EP-1130038-A1 CURABLE COMPOSITION TOKUYAMA CORPORATION (JP) 2001-09-05 EP disclosed
US-6194511-B1 COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND TOKUYAMA CORPORATION (JP) 2001-02-27 US disclosed
JP-2000186120-A CURABLE COMPOSITION TOKUYAMA CORP 2000-07-04 JP disclosed
EP-0965619-A1 Low odor, cold curable, (Meth)acylate reactive resin for floor coating, such réactive resin and the process for producing such floorcoating RÖHM GMBH (DE) 1999-12-22 EP disclosed
EP-0940694-A1 Photochromic curable composition TOKUYAMA CORPORATION (JP) 1999-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article C5, SCO2, ZYX TSHR 3533/4885ALDH1A1 1308/4885THRB 2158/4885
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES CRYAA, FEM1B, MAPRE1 TSHR 4218/4885ALDH1A1 588/4885THRB 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.